Advances in Mycobacterium siderophore-based drug discovery
Tuberculosis remains a public health threat of global proportions. Iron is a scarce resource indispensable to both host and pathogen during infection with Mycobacterium tuberculosis, the causative agent of tuberculosis. Siderophores are critical molecules for iron acquisition under iron-limiting con...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-06-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383511000098 |
id |
doaj-dfc77fb611e14474b4816bbd13ec2760 |
---|---|
record_format |
Article |
spelling |
doaj-dfc77fb611e14474b4816bbd13ec27602020-11-25T01:10:33ZengElsevierActa Pharmaceutica Sinica B2211-38352211-38432011-06-011181310.1016/j.apsb.2011.04.008Advances in Mycobacterium siderophore-based drug discoveryJun-li HeJian-ping XieTuberculosis remains a public health threat of global proportions. Iron is a scarce resource indispensable to both host and pathogen during infection with Mycobacterium tuberculosis, the causative agent of tuberculosis. Siderophores are critical molecules for iron acquisition under iron-limiting conditions and, as a very efficient pathogen, M. tuberculosis has evolved elaborate siderophores knowledge of which is being intensively translated into clinical practice. This paper summarizes the structures, types and physiological functions of Mycobacterium siderophores with emphasis on siderophore-inspired design of drugs and drug delivery vehicles.http://www.sciencedirect.com/science/article/pii/S2211383511000098TuberculosisMycobacterium tuberculosisSiderophoreDrug vectorDrug design |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jun-li He Jian-ping Xie |
spellingShingle |
Jun-li He Jian-ping Xie Advances in Mycobacterium siderophore-based drug discovery Acta Pharmaceutica Sinica B Tuberculosis Mycobacterium tuberculosis Siderophore Drug vector Drug design |
author_facet |
Jun-li He Jian-ping Xie |
author_sort |
Jun-li He |
title |
Advances in Mycobacterium siderophore-based drug discovery |
title_short |
Advances in Mycobacterium siderophore-based drug discovery |
title_full |
Advances in Mycobacterium siderophore-based drug discovery |
title_fullStr |
Advances in Mycobacterium siderophore-based drug discovery |
title_full_unstemmed |
Advances in Mycobacterium siderophore-based drug discovery |
title_sort |
advances in mycobacterium siderophore-based drug discovery |
publisher |
Elsevier |
series |
Acta Pharmaceutica Sinica B |
issn |
2211-3835 2211-3843 |
publishDate |
2011-06-01 |
description |
Tuberculosis remains a public health threat of global proportions. Iron is a scarce resource indispensable to both host and pathogen during infection with Mycobacterium tuberculosis, the causative agent of tuberculosis. Siderophores are critical molecules for iron acquisition under iron-limiting conditions and, as a very efficient pathogen, M. tuberculosis has evolved elaborate siderophores knowledge of which is being intensively translated into clinical practice. This paper summarizes the structures, types and physiological functions of Mycobacterium siderophores with emphasis on siderophore-inspired design of drugs and drug delivery vehicles. |
topic |
Tuberculosis Mycobacterium tuberculosis Siderophore Drug vector Drug design |
url |
http://www.sciencedirect.com/science/article/pii/S2211383511000098 |
work_keys_str_mv |
AT junlihe advancesinmycobacteriumsiderophorebaseddrugdiscovery AT jianpingxie advancesinmycobacteriumsiderophorebaseddrugdiscovery |
_version_ |
1725174081658028032 |